The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Vascular Smooth Muscle Cell Sirtuin 1 Protects Against DNA Damage and Inhibits Atherosclerosis
Abstract
Background—: Vascular smooth muscle cells (VSMCs) in human atherosclerosis manifest extensive DNA damage and activation of the DNA damage response, a pathway that coordinates cell cycle arrest and DNA repair, or can trigger apoptosis or cell senescence. Sirtuin 1 deacetylase (SIRT1) regulates cell ageing and energy metabolism and regulates the DNA damage response through multiple targets. However, the direct role of SIRT1 in atherosclerosis and how SIRT1 in VSMCs might regulate atherosclerosis are unknown. Methods and Results—: SIRT1 expression was reduced in human atherosclerotic plaques and VSMCs both derived from plaques and undergoing replicative senescence. SIRT1 inhibition reduced DNA repair and induced apoptosis, in part, through reduced activation of the repair protein Nijmegen Breakage Syndrome-1 but not p53. Fat feeding reduced SIRT1 and induced DNA damage in VSMCs. VSMCs from mice expressing inactive truncated SIRT1 (Δex4) showed increased oxidized low-density lipoprotein–induced DNA damage and senescence. ApoE −/− mice expressing SIRT1 Δex4 only in smooth muscle cells demonstrated increased DNA damage response activation and apoptosis, increased atherosclerosis, reduced relative fibrous cap thickness, and medial degeneration. Conclusions—: SIRT1 is reduced in human atherosclerosis and is a critical regulator of the DNA damage response and survival in VSMCs. VSMC SIRT1 protects against DNA damage, medial degeneration, and atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sirt1 has been shown to be atheroprotective in Apoe−/− mice.
“Sirt1 has been shown to be atheroprotective in apolipoprotein E-deficient (Apoe−/−) mice2–4 whereas genetic overexpression of Sirt1 in LDL-receptor-deficient (Ldlr−/−) mice enhanced atherosclerosis.5”
From The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression (2015) · cites this paper as [4]
Citations
Cites
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Matthews, C., Gorenne, I., Scott, S., Figg, N., Kirkpatrick, P., Ritchie, A., Goddard, M., & Bennett, M. (2006) · Circulation Research · doi:10.1161/01.res.0000233315.38086.bc · Cited by 615 · cited 11×
“We show that endogenous SIRT1 is reduced in human atherosclerosis, particularly in VSMCs. SIRT1 deficiency reduces DNA repair and promotes the activation of DNA damage markers and senescence.”
BackgroundInfluentialSelf-citationSirtuin Functions in Health and Disease
Yamamoto, H., Schoonjans, K., & Auwerx, J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0079 · Cited by 480 · cited 1×
“ing some forms of neurodegeneration, cancer, and metabolic decline including glucose intolerance and insulin resistance.(7) SIRT1 deacetylase targets include histone proteins and several transcription factors, including p53,(8,9) E2F-1,(10) and forkhead genes,(11) to suppress DNA damage-induced apoptosis.”
BackgroundSIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
Vaquero, A., Scher, M., Erdjument-Bromage, H., Tempst, P., Serrano, L., & Reinberg, D. (2007) · Nature · doi:10.1038/nature06268 · Cited by 439
Clarke, M. C. H., Littlewood, T. D., Figg, N., Maguire, J. J., Davenport, A. P., Goddard, M., & Bennett, M. R. (2008) · Circulation Research · doi:10.1161/circresaha.108.175976 · Cited by 396
Self-citationKemper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., Tsang, S., Wu, S.-Y., Chiang, C.-M., & Veenstra, T. D. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.009 · Cited by 332
Flagged first, then by citations
Research works printed but not linked: 41
- 10.1161/hh0701.088684 · DOI
- 10.1161/circresaha.108.182899 · DOI
- 10.1038/nature08467 · DOI · Paper page
- 10.1016/j.dnarep.2004.06.001 · DOI
- 10.1038/nature08197 · DOI
- 10.1016/S0092-8674(01)00524-4 · DOI · Paper page
- 10.1016/S0092-8674(01)00527-X · DOI
- 10.1038/ncb1468 · DOI
- 10.1016/j.ccr.2008.09.001 · DOI
- 10.1016/j.cell.2008.10.025 · DOI · Paper page
- 10.1016/j.molcel.2007.05.029 · DOI
- 10.1161/circresaha.111.246488 · DOI
- 10.1073/pnas.0704329104 · DOI · Paper page
- 10.1093/cvr/cvn224 · DOI · Paper page
- 10.1093/eurheartj/ehq107 · DOI · Paper page
- 10.1016/j.molcel.2007.07.032 · DOI
- 10.1016/j.cmet.2011.10.007 · DOI · Paper page
- 10.1161/atvbaha.110.216739 · DOI
- 10.1161/circresaha.110.237875 · DOI
- 10.1074/jbc.C700018200 · DOI
- 10.1016/j.febslet.2009.08.031 · DOI
- 10.1073/pnas.1934713100 · DOI · Paper page
- 10.1161/circresaha.110.218966 · DOI
- 10.1172/JCI39319 · DOI
- 10.1038/nm1459 · DOI
- 10.4161/cc.10.4.14863 · DOI · Paper page
- 10.1016/S0008-6363(98)00311-3 · DOI
- 10.1172/JCI117917 · DOI
- 10.1016/j.molcel.2007.01.011 · DOI
- 10.1038/nm1228 · DOI
- 10.1016/j.cell.2008.03.030 · DOI · Paper page
- 10.1016/S0092-8674(04)00126-6 · DOI
- 10.1016/j.cmet.2011.03.013 · DOI
- 10.1016/j.cmet.2011.03.004 · DOI · Paper page
- 10.1074/jbc.M710098200 · DOI
- 10.1016/j.yjmcc.2007.08.008 · DOI
- 10.1016/0002-9149(70)90006-8 · DOI
- 10.1016/S0002-9149(77)80004-0 · DOI
- Saruk M, Eisenstein R. Aortic lesion in Marfan syndrome: the ultrastructure of cystic medial degeneration. Arch Pathol Lab Med. 1977;101:74–77.
- 10.1136/jcp.39.10.1074 · DOI
- 10.1016/S0002-9149(77)80005-2 · DOI
Cited by
Sorted by citations
Cellular and molecular biology of aging endothelial cells
Donato, A. J., Morgan, R. G., Walker, A. E., & Lesniewski, L. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.021 · Cited by 538
Calorie restriction and sirtuins revisited
Guarente, L. (2013) · Genes & Development · doi:10.1101/gad.227439.113 · Cited by 464
Grootaert, M. O., da Costa Martins, P. A., Bitsch, N., Pintelon, I., De Meyer, G. R., Martinet, W., & Schrijvers, D. M. (2015) · Autophagy · doi:10.1080/15548627.2015.1096485 · Cited by 267
“VSMC-specific deletion of SIRT1 deacetylase in apoe¡/¡ mice promotes atherosclerosis associated with increased DNA damage and senescence.(60) Finally, it is worthwhile to mention that MTOR (mechanistic target of rapamycin [serine/threonine kinase])-inhibitors such as rapamycin (or rapalogs) are able to stimulate autop…”
BackgroundChen, H.-Z., Wang, F., Gao, P., Pei, J.-F., Liu, Y., Xu, T.-T., Tang, X., Fu, W.-Y., Lu, J., Yan, Y.-F., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308895 · Cited by 265
The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system
Kietzmann, T., Petry, A., Shvetsova, A., Gerhold, J. M., & Görlach, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13792 · Cited by 253
Ageing induced vascular smooth muscle cell senescence in atherosclerosis
Uryga, A. K., & Bennett, M. R. (2016) · The Journal of Physiology · doi:10.1113/jp270923 · Cited by 160
Self-citationMiranda, M. X., van Tits, L. J., Lohmann, C., Arsiwala, T., Winnik, S., Tailleux, A., Stein, S., Gomes, A. P., Suri, V., Ellis, J. L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu095 · Cited by 153
Shah, A., Gray, K., Figg, N., Finigan, A., Starks, L., & Bennett, M. (2018) · Circulation · doi:10.1161/circulationaha.117.033249 · Cited by 121
Self-citationChan, S.-H., Hung, C.-H., Shih, J.-Y., Chu, P.-M., Cheng, Y.-H., Lin, H.-C., Hsieh, P.-L., & Tsai, K.-L. (2018) · Redox Biology · doi:10.1016/j.redox.2017.08.016 · Cited by 76
Afonso, P., Auclair, M., Caron-Debarle, M., & Capeau, J. (2017) · Antiviral Therapy · doi:10.3851/imp3160 · Cited by 28
Hernandez Torres, L. D., Rezende, F., Peschke, E., Will, O., Hövener, J.-B., Spiecker, F., Özorhan, Ü., Lampe, J., Stölting, I., Aherrahrou, Z., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1338458 · Cited by 8
Metadata
- Authors
- Gorenne, I., Kumar, S., Gray, K., Figg, N., Yu, H., Mercer, J., & Bennett, M.
- Affiliations
- From University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK.
- Venue
- Circulation
- Published
- 2013-01-22
- Volume
- 127
- Issue
- 3
- Pages
- 386-396
- ISSN
- 0009-7322
- 1524-4539
- Cited by
- 238
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review